Clinical Trial Update: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial of tipifarnib in older adults with acute myeloid leukemia has completed, with results posted in January 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Tipifarnib (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2014-01-06